Assistant Professor, Pediatrics, Children's Hospital, Harvard Medical School
Pediatric Hematology & Oncology
Dr. Leslie E. Lehmann, MD
|
|
Give Review
Leslie Lehmann works in the field of Pediatric Hematology & Oncology. He went to medical school at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He over the years received 1 awards: "Regional Top Doctor". Leslie E. Lehmann, MD is a published physician as well. He has 40 publications published. The latest was: Cytogenetic changes in radiation-induced tumors of the thyroid. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families.
- Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation.
- Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation.
- Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children.
- Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems.
- Novel dominant β-thalassemia: Hb Boston-Kuwait [codon 139/140(+T)].
- The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or Cancer chemother...
- Semen analysis in adolescent Cancer patients prior to bone marrow transplantation: when is it too late for fertility preservation?
- Impact of a Conservative Red Blood Cell Transfusion Strategy in Children Undergoing Hematopoietic Stem Cell Transplantation.
- 25-hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant.
- Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation.
- Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients.
- Tolerability of pravastatin in pediatric hematopoietic stem cell transplant patients with bronchiolitis obliterans.
- Is blood thicker than water?: ethics of hematopoietic stem cell donation by biological siblings of adopted children.
- Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic Graft-versus-host disease (cGVHD).
- Helicobacter pylori associated gastric Burkitt lymphoma.
- Transverse myelitis after therapy for primitive neuroectodermal tumors.
- Oral chronic Graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
- Dyskeratosis congenita vs. chronic Graft versus host disease: report of a case and a review of the literature.
- A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 18-2003. A 15-year-old girl with pain in the left leg and back, pruritus...
- Chromosome translocations in thyroid tissues from Belarussian children exposed to radioiodine from the Chernobyl accident, measured by FISH-painting.
- Cytogenetic changes in radiation-induced tumors of the thyroid.
- Neuropathology of a fatal case of posterior reversible encephalopathy syndrome.
- Childhood T-cell Acute lymphoblastic leukemia: the Dana-Farber Cancer Institute Acute lymphoblastic leukemia consortium experience.
- Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation.
- Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT.
- End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care.
- Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for Acute myelogenous leukemia.
- Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in Graft-derived neutrophils.
- Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem cell transplantation.
- Evaluation of pentostatin in corticosteroid-refractory chronic Graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.
- Relapsed Acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
- Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation.
- Calcineurin inhibitor-associated oral inflammatory polyps after transplantation.
- Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory Acute promyelocytic leukemia in childhood.
- Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation.
- Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.
- A novel pattern of transaminase elevation associated with autologous transplant for neuroblastoma.
Schools
Duke University School Of Medicine
Duke University Med Center
Mass Gen Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Graft vs Host Disease
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- POMCO Group
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
Education
-
Duke University Hospital -
Massachusetts General Hospital -
Duke University School of Medicine
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1801962329 | |
| NPPES Provider LastName | LEHMANN | |
| NPPES Provider FirstName | LESLIE | |
| NPPES Provider ZIPCode | 14217 | |
| NPPES Provider State | NY | |
| Specialty Description | Family Practice | |
| Total Claim Count | 1435.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 31.0 | |
| Percent Opioid Claims | 2.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801962329 |
| Last Name Of The Provider | LEHMANN |
| First Name Of The Provider | LESLIE |
| View All |
Similar Doctors
|
|
Dr. Lisa B. Kenney, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pratiti Bandopadhayay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynda M. Vrooman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven P. Margossian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Law, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elisha D. Waldman, MD
This Doctor is OpenDoctor Recommended.
|